Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 41 entries
Sorted by: Best Match Show Resources per page
Peroneus Tertius Tendon Tear: A Rare Cause of Lateral Ankle Pain.

Cureus

Derrick E, Flores M, Scherer K, Bancroft L.
PMID: 27226938
Cureus. 2016 Apr 19;8(4):e577. doi: 10.7759/cureus.577.

The peroneus tertius (PT) muscle is a variably present muscle, uncommonly found in humans. Injury to the PT tendon is rare with virtually no cases reported in the literature. As a consequence of the rarity of this injury, there...

Cite
Derrick E, Flores M, Scherer K, et al. Peroneus Tertius Tendon Tear: A Rare Cause of Lateral Ankle Pain. Cureus. 2016;8(4):e577doi: 10.7759/cureus.577.
Derrick, E., Flores, M., Scherer, K., & Bancroft, L. (2016). Peroneus Tertius Tendon Tear: A Rare Cause of Lateral Ankle Pain. Cureus, 8(4), e577. https://doi.org/10.7759/cureus.577
Derrick, Edward, et al. "Peroneus Tertius Tendon Tear: A Rare Cause of Lateral Ankle Pain." Cureus vol. 8,4 (2016): e577. doi: https://doi.org/10.7759/cureus.577
Derrick E, Flores M, Scherer K, Bancroft L. Peroneus Tertius Tendon Tear: A Rare Cause of Lateral Ankle Pain. Cureus. 2016 Apr 19;8(4):e577. doi: 10.7759/cureus.577. PMID: 27226938; PMCID: PMC4873314.
Copy Download .nbib Format: NLM
Leptospiral pathogenomics.

Pathogens (Basel, Switzerland)

Lehmann JS, Matthias MA, Vinetz JM, Fouts DE.
PMID: 25437801
Pathogens. 2014 Apr 10;3(2):280-308. doi: 10.3390/pathogens3020280.

Leptospirosis, caused by pathogenic spirochetes belonging to the genus Leptospira, is a zoonosis with important impacts on human and animal health worldwide. Research on the mechanisms of Leptospira pathogenesis has been hindered due to slow growth of infectious strains,...

Cite
Lehmann JS, Matthias MA, Vinetz JM, et al. Leptospiral pathogenomics. Pathogens. 2014;3(2):280-308doi: 10.3390/pathogens3020280.
Lehmann, J. S., Matthias, M. A., Vinetz, J. M., & Fouts, D. E. (2014). Leptospiral pathogenomics. Pathogens (Basel, Switzerland), 3(2), 280-308. https://doi.org/10.3390/pathogens3020280
Lehmann, Jason S, et al. "Leptospiral pathogenomics." Pathogens (Basel, Switzerland) vol. 3,2 (2014): 280-308. doi: https://doi.org/10.3390/pathogens3020280
Lehmann JS, Matthias MA, Vinetz JM, Fouts DE. Leptospiral pathogenomics. Pathogens. 2014 Apr 10;3(2):280-308. doi: 10.3390/pathogens3020280. PMID: 25437801; PMCID: PMC4243447.
Copy Download .nbib Format: NLM
Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus.

Nature communications

Llorente C, Jepsen P, Inamine T, Wang L, Bluemel S, Wang HJ, Loomba R, Bajaj JS, Schubert ML, Sikaroodi M, Gillevet PM, Xu J, Kisseleva T, Ho SB, DePew J, Du X, Sørensen HT, Vilstrup H, Nelson KE, Brenner DA, Fouts DE, Schnabl B.
PMID: 29233961
Nat Commun. 2017 Dec 12;8(1):2137. doi: 10.1038/s41467-017-01779-8.

In the original PDF version of this Article, which was published on 16 October 2017, the publication date was incorrectly given as 10 October 2017. This has now been corrected in the PDF; the HTML version of the paper...

Cite
Llorente C, Jepsen P, Inamine T, et al. Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat Commun. 2017;8(1):2137doi: 10.1038/s41467-017-01779-8.
Llorente, C., Jepsen, P., Inamine, T., Wang, L., Bluemel, S., Wang, H. J., Loomba, R., Bajaj, J. S., Schubert, M. L., Sikaroodi, M., Gillevet, P. M., Xu, J., Kisseleva, T., Ho, S. B., DePew, J., Du, X., Sørensen, H. T., Vilstrup, H., Nelson, K. E., Brenner, D. A., Fouts, D. E., & Schnabl, B. (2017). Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nature communications, 8(1), 2137. https://doi.org/10.1038/s41467-017-01779-8
Llorente, Cristina, et al. "Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus." Nature communications vol. 8,1 (2017): 2137. doi: https://doi.org/10.1038/s41467-017-01779-8
Llorente C, Jepsen P, Inamine T, Wang L, Bluemel S, Wang HJ, Loomba R, Bajaj JS, Schubert ML, Sikaroodi M, Gillevet PM, Xu J, Kisseleva T, Ho SB, DePew J, Du X, Sørensen HT, Vilstrup H, Nelson KE, Brenner DA, Fouts DE, Schnabl B. Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat Commun. 2017 Dec 12;8(1):2137. doi: 10.1038/s41467-017-01779-8. PMID: 29233961; PMCID: PMC5727102.
Copy Download .nbib Format: NLM
Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder.

Frontiers in physiology

Hartmann P, Lang S, Zeng S, Duan Y, Zhang X, Wang Y, Bondareva M, Kruglov A, Fouts DE, Stärkel P, Schnabl B.
PMID: 34349667
Front Physiol. 2021 Jul 19;12:699253. doi: 10.3389/fphys.2021.699253. eCollection 2021.

BACKGROUND: Alcohol-associated liver disease (ALD) is an important cause of morbidity and mortality worldwide. The intestinal microbiota is involved in the development and progression of ALD; however, little is known about commensal fungi therein.METHODS: We studied the dynamic changes...

Cite
Hartmann P, Lang S, Zeng S, et al. Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder. Front Physiol. 2021;12:699253doi: 10.3389/fphys.2021.699253.
Hartmann, P., Lang, S., Zeng, S., Duan, Y., Zhang, X., Wang, Y., Bondareva, M., Kruglov, A., Fouts, D. E., Stärkel, P., & Schnabl, B. (2021). Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder. Frontiers in physiology, 12699253. https://doi.org/10.3389/fphys.2021.699253
Hartmann, Phillipp, et al. "Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder." Frontiers in physiology vol. 12 (2021): 699253. doi: https://doi.org/10.3389/fphys.2021.699253
Hartmann P, Lang S, Zeng S, Duan Y, Zhang X, Wang Y, Bondareva M, Kruglov A, Fouts DE, Stärkel P, Schnabl B. Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder. Front Physiol. 2021 Jul 19;12:699253. doi: 10.3389/fphys.2021.699253. eCollection 2021. PMID: 34349667; PMCID: PMC8327211.
Copy Download .nbib Format: NLM
Improved metagenomic analysis with Kraken 2.

Genome biology

Wood DE, Lu J, Langmead B.
PMID: 31779668
Genome Biol. 2019 Nov 28;20(1):257. doi: 10.1186/s13059-019-1891-0.

Although Kraken's k-mer-based approach provides a fast taxonomic classification of metagenomic sequence data, its large memory requirements can be limiting for some applications. Kraken 2 improves upon Kraken 1 by reducing memory usage by 85%, allowing greater amounts of...

Cite
Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20(1):257doi: 10.1186/s13059-019-1891-0.
Wood, D. E., Lu, J., & Langmead, B. (2019). Improved metagenomic analysis with Kraken 2. Genome biology, 20(1), 257. https://doi.org/10.1186/s13059-019-1891-0
Wood, Derrick E, et al. "Improved metagenomic analysis with Kraken 2." Genome biology vol. 20,1 (2019): 257. doi: https://doi.org/10.1186/s13059-019-1891-0
Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019 Nov 28;20(1):257. doi: 10.1186/s13059-019-1891-0. PMID: 31779668; PMCID: PMC6883579.
Copy Download .nbib Format: NLM
Complete Genome Sequence of Staphylococcus aureus Phage SA75, Isolated from Goat Feces.

Microbiology resource announcements

D'Souza R, White RC, Buzzeo R, Goglin K, Vashee S, Lee Y, Son B, Ryu S, Fouts DE.
PMID: 32299871
Microbiol Resour Announc. 2020 Apr 16;9(16). doi: 10.1128/MRA.00114-20.

Antibiotic-resistant

Cite
D'Souza R, White RC, Buzzeo R, et al. Complete Genome Sequence of Staphylococcus aureus Phage SA75, Isolated from Goat Feces. Microbiol Resour Announc. 2020;9(16)doi: 10.1128/MRA.00114-20.
D'Souza, R., White, R. C., Buzzeo, R., Goglin, K., Vashee, S., Lee, Y., Son, B., Ryu, S., & Fouts, D. E. (2020). Complete Genome Sequence of Staphylococcus aureus Phage SA75, Isolated from Goat Feces. Microbiology resource announcements, 9(16), . https://doi.org/10.1128/MRA.00114-20
D'Souza, Roshan, et al. "Complete Genome Sequence of Staphylococcus aureus Phage SA75, Isolated from Goat Feces." Microbiology resource announcements vol. 9,16 (2020). doi: https://doi.org/10.1128/MRA.00114-20
D'Souza R, White RC, Buzzeo R, Goglin K, Vashee S, Lee Y, Son B, Ryu S, Fouts DE. Complete Genome Sequence of Staphylococcus aureus Phage SA75, Isolated from Goat Feces. Microbiol Resour Announc. 2020 Apr 16;9(16). doi: 10.1128/MRA.00114-20. PMID: 32299871; PMCID: PMC7163009.
Copy Download .nbib Format: NLM
In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant .

Pharmaceuticals (Basel, Switzerland)

Nguyen LP, Park CS, Pinto NA, Lee H, Seo HS, Vu TN, Mai H, Pham AHT, Jang E, Cho YL, Goglin K, Nguyen K, White R, D'Souza R, Fouts DE, Yong D.
PMID: 33923801
Pharmaceuticals (Basel). 2021 Apr 16;14(4). doi: 10.3390/ph14040370.

The siderophore-antibiotic conjugate LCB10-0200 (a.k.a. GT-1) has been developed to combat multidrug-resistant Gram-negative bacteria. In this study, the in vitro activity of LCB10-0200 and LCB10-0200/avibactam (AVI) has been investigated against carbapenem-resistant

Cite
Nguyen LP, Park CS, Pinto NA, et al. In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant . Pharmaceuticals (Basel). 2021;14(4)doi: 10.3390/ph14040370.
Nguyen, L. P., Park, C. S., Pinto, N. A., Lee, H., Seo, H. S., Vu, T. N., Mai, H., Pham, A. H. T., Jang, E., Cho, Y. L., Goglin, K., Nguyen, K., White, R., D'Souza, R., Fouts, D. E., & Yong, D. (2021). In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant . Pharmaceuticals (Basel, Switzerland), 14(4), . https://doi.org/10.3390/ph14040370
Nguyen, Le Phuong, et al. "In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant ." Pharmaceuticals (Basel, Switzerland) vol. 14,4 (2021). doi: https://doi.org/10.3390/ph14040370
Nguyen LP, Park CS, Pinto NA, Lee H, Seo HS, Vu TN, Mai H, Pham AHT, Jang E, Cho YL, Goglin K, Nguyen K, White R, D'Souza R, Fouts DE, Yong D. In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant . Pharmaceuticals (Basel). 2021 Apr 16;14(4). doi: 10.3390/ph14040370. PMID: 33923801; PMCID: PMC8072773.
Copy Download .nbib Format: NLM
The fecal mycobiome in non-alcoholic fatty liver disease.

Journal of hepatology

Demir M, Lang S, Hartmann P, Duan Y, Martin A, Miyamoto Y, Bondareva M, Zhang X, Wang Y, Kasper P, Bang C, Roderburg C, Tacke F, Steffen HM, Goeser T, Kruglov A, Eckmann L, Stärkel P, Fouts DE, Schnabl B.
PMID: 34896404
J Hepatol. 2021 Dec 09; doi: 10.1016/j.jhep.2021.11.029. Epub 2021 Dec 09.

BACKGROUND & AIMS: Studies investigating the gut-liver axis have largely focused on bacteria, whereas little is known about commensal fungi. We characterized fecal fungi in patients with non-alcoholic fatty liver disease (NAFLD) and investigated their role in a fecal...

Cite
Demir M, Lang S, Hartmann P, et al. The fecal mycobiome in non-alcoholic fatty liver disease. J Hepatol. 2021;doi: 10.1016/j.jhep.2021.11.029.
Demir, M., Lang, S., Hartmann, P., Duan, Y., Martin, A., Miyamoto, Y., Bondareva, M., Zhang, X., Wang, Y., Kasper, P., Bang, C., Roderburg, C., Tacke, F., Steffen, H. M., Goeser, T., Kruglov, A., Eckmann, L., Stärkel, P., Fouts, D. E., & Schnabl, B. (2021). The fecal mycobiome in non-alcoholic fatty liver disease. Journal of hepatology, . https://doi.org/10.1016/j.jhep.2021.11.029
Demir, Münevver, et al. "The fecal mycobiome in non-alcoholic fatty liver disease." Journal of hepatology vol. (2021). doi: https://doi.org/10.1016/j.jhep.2021.11.029
Demir M, Lang S, Hartmann P, Duan Y, Martin A, Miyamoto Y, Bondareva M, Zhang X, Wang Y, Kasper P, Bang C, Roderburg C, Tacke F, Steffen HM, Goeser T, Kruglov A, Eckmann L, Stärkel P, Fouts DE, Schnabl B. The fecal mycobiome in non-alcoholic fatty liver disease. J Hepatol. 2021 Dec 09; doi: 10.1016/j.jhep.2021.11.029. Epub 2021 Dec 09. PMID: 34896404.
Copy Download .nbib Format: NLM
Unexpected cross-species contamination in genome sequencing projects.

PeerJ

Merchant S, Wood DE, Salzberg SL.
PMID: 25426337
PeerJ. 2014 Nov 20;2:e675. doi: 10.7717/peerj.675. eCollection 2014.

The raw data from a genome sequencing project sometimes contains DNA from contaminating organisms, which may be introduced during sample collection or sequence preparation. In some instances, these contaminants remain in the sequence even after assembly and deposition of...

Cite
Merchant S, Wood DE, Salzberg SL. Unexpected cross-species contamination in genome sequencing projects. PeerJ. 2014;2:e675doi: 10.7717/peerj.675.
Merchant, S., Wood, D. E., & Salzberg, S. L. (2014). Unexpected cross-species contamination in genome sequencing projects. PeerJ, 2e675. https://doi.org/10.7717/peerj.675
Merchant, Samier, et al. "Unexpected cross-species contamination in genome sequencing projects." PeerJ vol. 2 (2014): e675. doi: https://doi.org/10.7717/peerj.675
Merchant S, Wood DE, Salzberg SL. Unexpected cross-species contamination in genome sequencing projects. PeerJ. 2014 Nov 20;2:e675. doi: 10.7717/peerj.675. eCollection 2014. PMID: 25426337; PMCID: PMC4243333.
Copy Download .nbib Format: NLM
Vesicoureteral Reflux Index: Predicting Primary Vesicoureteral Reflux Resolution in Children Diagnosed after Age 24 Months.

The Journal of urology

Garcia-Roig M, Ridley DE, McCracken C, Arlen AM, Cooper CS, Kirsch AJ.
PMID: 27939835
J Urol. 2017 Apr;197(4):1150-1157. doi: 10.1016/j.juro.2016.12.008. Epub 2016 Dec 09.

PURPOSE: The Vesicoureteral Reflux Index is a validated tool that reliably predicts spontaneous resolution of reflux or at least 2 grades of improvement for patients diagnosed before age 24 months. We evaluated the Vesicoureteral Reflux Index in children older...

Cite
Garcia-Roig M, Ridley DE, McCracken C, et al. Vesicoureteral Reflux Index: Predicting Primary Vesicoureteral Reflux Resolution in Children Diagnosed after Age 24 Months. J Urol. 2016;197(4):1150-1157doi: 10.1016/j.juro.2016.12.008.
Garcia-Roig, M., Ridley, D. E., McCracken, C., Arlen, A. M., Cooper, C. S., & Kirsch, A. J. (2017). Vesicoureteral Reflux Index: Predicting Primary Vesicoureteral Reflux Resolution in Children Diagnosed after Age 24 Months. The Journal of urology, 197(4), 1150-1157. https://doi.org/10.1016/j.juro.2016.12.008
Garcia-Roig, Michael, et al. "Vesicoureteral Reflux Index: Predicting Primary Vesicoureteral Reflux Resolution in Children Diagnosed after Age 24 Months." The Journal of urology vol. 197,4 (2017): 1150-1157. doi: https://doi.org/10.1016/j.juro.2016.12.008
Garcia-Roig M, Ridley DE, McCracken C, Arlen AM, Cooper CS, Kirsch AJ. Vesicoureteral Reflux Index: Predicting Primary Vesicoureteral Reflux Resolution in Children Diagnosed after Age 24 Months. J Urol. 2017 Apr;197(4):1150-1157. doi: 10.1016/j.juro.2016.12.008. Epub 2016 Dec 09. PMID: 27939835.
Copy Download .nbib Format: NLM
Intestinal virome and therapeutic potential of bacteriophages in liver disease.

Journal of hepatology

Hsu CL, Duan Y, Fouts DE, Schnabl B.
PMID: 34437908
J Hepatol. 2021 Dec;75(6):1465-1475. doi: 10.1016/j.jhep.2021.08.003. Epub 2021 Aug 24.

Humans harbour a large quantity of microbes in the intestinal tract and have evolved symbiotic relationships with many of them. However, several specific bacterial pathobionts are associated with liver disease pathogenesis. Although bacteriophages (phages) and eukaryotic viruses (collectively known...

Cite
Hsu CL, Duan Y, Fouts DE, et al. Intestinal virome and therapeutic potential of bacteriophages in liver disease. J Hepatol. 2021;75(6):1465-1475doi: 10.1016/j.jhep.2021.08.003.
Hsu, C. L., Duan, Y., Fouts, D. E., & Schnabl, B. (2021). Intestinal virome and therapeutic potential of bacteriophages in liver disease. Journal of hepatology, 75(6), 1465-1475. https://doi.org/10.1016/j.jhep.2021.08.003
Hsu, Cynthia L, et al. "Intestinal virome and therapeutic potential of bacteriophages in liver disease." Journal of hepatology vol. 75,6 (2021): 1465-1475. doi: https://doi.org/10.1016/j.jhep.2021.08.003
Hsu CL, Duan Y, Fouts DE, Schnabl B. Intestinal virome and therapeutic potential of bacteriophages in liver disease. J Hepatol. 2021 Dec;75(6):1465-1475. doi: 10.1016/j.jhep.2021.08.003. Epub 2021 Aug 24. PMID: 34437908.
Copy Download .nbib Format: NLM
Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance.

Frontiers in bioengineering and biotechnology

Nath SC, Harper L, Rancourt DE.
PMID: 33324625
Front Bioeng Biotechnol. 2020 Nov 26;8:599674. doi: 10.3389/fbioe.2020.599674. eCollection 2020.

Cell-based therapy (CBT) is attracting much attention to treat incurable diseases. In recent years, several clinical trials have been conducted using human pluripotent stem cells (hPSCs), and other potential therapeutic cells. Various private- and government-funded organizations are investing in...

Cite
Nath SC, Harper L, Rancourt DE. Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance. Front Bioeng Biotechnol. 2020;8:599674doi: 10.3389/fbioe.2020.599674.
Nath, S. C., Harper, L., & Rancourt, D. E. (2020). Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance. Frontiers in bioengineering and biotechnology, 8599674. https://doi.org/10.3389/fbioe.2020.599674
Nath, Suman C, et al. "Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance." Frontiers in bioengineering and biotechnology vol. 8 (2020): 599674. doi: https://doi.org/10.3389/fbioe.2020.599674
Nath SC, Harper L, Rancourt DE. Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance. Front Bioeng Biotechnol. 2020 Nov 26;8:599674. doi: 10.3389/fbioe.2020.599674. eCollection 2020. PMID: 33324625; PMCID: PMC7726241.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 41 entries